The Disease Forecasting Company.
After successful expansion into North America last year, Airfinity is proud to be opening a new office in Japan to provide a formal base for its activities across the APAC region.
Read More →
Airfinity launches obesity intelligence solution to forecast and simulate obesity related outcomes
Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe
Airfinity Named The Financial Times' Healthcare Tech Champion 2023
Airfinity upgrades global biorisk platform
Airfinity named among Bloomberg’s UK Startups to Watch 2023
France faces massive increase in dengue cases by 2030
Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death
View All →
The race to develop the next generation of weight-loss drugs
Financial Times | Apr 1, 2024
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study
Journal of Infection | Feb 29, 2024
Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report
ScienceDirect | Feb 23, 2024
England and Wales in whooping cough epidemic, experts warn
The Telegraph | Feb 16, 2024
View All →
What's happening in a given disease area?
Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.
Identify the true need for a vaccine or a treatment.
Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.
Maximise impact to save lives
Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.
Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”
Iskra Reic, Executive Vice-President
Astrazeneca
“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”
Sir John Bell ,
University of Oxford